Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- BAF308 - Provider product page
- Provider
- R&D Systems
- Product name
- Human Flt-3 Ligand/FLT3L Biotinylated Antibody
- Antibody type
- Polyclonal
- Description
- Antigen Affinity-purified. Detects human Flt-3 Ligand/FLT3L in ELISAs and Western blots. In sandwich immunoassays, less than 0.05% cross-reactivity with recombinant human (rh) PlGF, recombinant mouse Flt-3 Ligand/FLT3L, rhVEGF and rhFlt-1 Fc chimera is observed.
- Reactivity
- Human
- Host
- Goat
- Conjugate
- Biotin
- Antigen sequence
AAA17999- Isotype
- IgG
- Vial size
- 50 ug
- Concentration
- LYOPH
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Submitted references Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers.
Expression of CCL20 and granulocyte-macrophage colony-stimulating factor, but not Flt3-L, from modified vaccinia virus ankara enhances antiviral cellular and humoral immune responses.
Long-term maintenance of gp120-specific immune responses by genetic vaccination with the HIV-1 envelope genes linked to the gene encoding Flt-3 ligand.
Long-term maintenance of gp120-specific immune responses by genetic vaccination with the HIV-1 envelope genes linked to the gene encoding Flt-3 ligand.
Anandasabapathy N, Breton G, Hurley A, Caskey M, Trumpfheller C, Sarma P, Pring J, Pack M, Buckley N, Matei I, Lyden D, Green J, Hawthorne T, Marsh HC, Yellin M, Davis T, Keler T, Schlesinger SJ
Bone marrow transplantation 2015 Jul;50(7):924-30
Bone marrow transplantation 2015 Jul;50(7):924-30
Expression of CCL20 and granulocyte-macrophage colony-stimulating factor, but not Flt3-L, from modified vaccinia virus ankara enhances antiviral cellular and humoral immune responses.
Chavan R, Marfatia KA, An IC, Garber DA, Feinberg MB
Journal of virology 2006 Aug;80(15):7676-87
Journal of virology 2006 Aug;80(15):7676-87
Long-term maintenance of gp120-specific immune responses by genetic vaccination with the HIV-1 envelope genes linked to the gene encoding Flt-3 ligand.
Sailaja G, Husain S, Nayak BP, Jabbar AM
Journal of immunology (Baltimore, Md. : 1950) 2003 Mar 1;170(5):2496-507
Journal of immunology (Baltimore, Md. : 1950) 2003 Mar 1;170(5):2496-507
Long-term maintenance of gp120-specific immune responses by genetic vaccination with the HIV-1 envelope genes linked to the gene encoding Flt-3 ligand.
Sailaja G, Husain S, Nayak BP, Jabbar AM
Journal of immunology (Baltimore, Md. : 1950) 2003 Mar 1;170(5):2496-507
Journal of immunology (Baltimore, Md. : 1950) 2003 Mar 1;170(5):2496-507
No comments: Submit comment
No validations: Submit validation data